BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SH009 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SH009\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07390838-2724@assetmemo.bio
DTSTAMP:20261121T005405Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:SH009: Phase 1 readout est. (NCT07390838)
DESCRIPTION:SH009\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Study o
 f SH009 Injection in Patients With Advanced Solid Tumors.\nEstimated prima
 ry completion: 30 December 2026. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/sh009#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT07390838
URL:https://assetmemo.bio/drug/sh009#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
